Scarica l'app Stockscreener
87.21
2.30%
1.96
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Forum
Previsione
Frazionamento azionario
Precedente Chiudi:
$85.25
Aprire:
$85.41
Volume 24 ore:
478.99K
Relative Volume:
0.81
Capitalizzazione di mercato:
$5.21B
Reddito:
$1.54B
Utile/perdita netta:
$139.34M
Rapporto P/E:
37.64
EPS:
2.317
Flusso di cassa netto:
$217.40M
1 W Prestazione:
+2.16%
1M Prestazione:
+0.02%
6M Prestazione:
+27.04%
1 anno Prestazione:
+5.73%
Intervallo 1D:
$85.41
$87.62
Intervallo di 1 settimana:
$83.94
$88.90
Portata 52W:
$59.74
$94.75
Merit Medical Systems Inc Stock (MMSI) Company Profile
Nome
Merit Medical Systems Inc
Settore
Industria
Telefono
(801) 253-1600
Indirizzo
1600 WEST MERIT PARK WAY, SOUTH JORDAN, UT
Compare MMSI vs ISRG, BDX, RMD, MDLN, ALC
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
MMSI
Merit Medical Systems Inc
|
87.21 | 5.21B | 1.54B | 139.34M | 217.40M | 2.317 |
ISRG
Intuitive Surgical Inc
|
423.96 | 149.78B | 11.03B | 3.16B | 3.22B | 8.7251 |
BDX
Becton Dickinson Co
|
183.75 | 50.05B | 21.37B | 1.41B | 3.07B | 3.9437 |
RMD
Resmed Inc
|
230.05 | 32.35B | 5.54B | 1.52B | 1.74B | 10.37 |
MDLN
Medline Inc
|
36.26 | 31.81B | 29.14B | 1.07B | 1.05B | 1.1956 |
ALC
Alcon Inc
|
64.11 | 30.99B | 10.63B | 819.00M | 1.59B | 1.6577 |
Merit Medical Systems Inc Stock (MMSI) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2026-02-26 | Downgrade | Wells Fargo | Overweight → Equal Weight |
| 2026-02-06 | Iniziato | BTIG Research | Buy |
| 2025-03-28 | Iniziato | JP Morgan | Overweight |
| 2024-12-11 | Aggiornamento | Wells Fargo | Equal Weight → Overweight |
| 2024-06-28 | Iniziato | Robert W. Baird | Outperform |
| 2024-04-11 | Iniziato | CL King | Buy |
| 2024-02-07 | Iniziato | BofA Securities | Neutral |
| 2023-12-21 | Aggiornamento | Canaccord Genuity | Hold → Buy |
| 2022-12-20 | Downgrade | Canaccord Genuity | Buy → Hold |
| 2021-01-05 | Aggiornamento | Needham | Hold → Buy |
| 2020-09-28 | Aggiornamento | Wells Fargo | Underweight → Equal Weight |
| 2020-02-25 | Downgrade | Barrington Research | Outperform → Mkt Perform |
| 2020-02-03 | Aggiornamento | Raymond James | Mkt Perform → Outperform |
| 2019-12-12 | Downgrade | Wells Fargo | Market Perform → Underperform |
| 2019-09-24 | Iniziato | Oppenheimer | Outperform |
| 2019-09-10 | Downgrade | Raymond James | Outperform → Mkt Perform |
| 2019-07-26 | Downgrade | Needham | Buy → Hold |
| 2019-07-26 | Downgrade | Wells Fargo | Outperform → Market Perform |
| 2018-10-02 | Reiterato | Needham | Buy |
| 2018-08-07 | Downgrade | BofA/Merrill | Buy → Underperform |
| 2018-07-24 | Reiterato | Needham | Buy |
| 2018-06-01 | Reiterato | Needham | Buy |
| 2018-05-18 | Reiterato | SunTrust | Buy |
| 2018-04-26 | Reiterato | Needham | Buy |
| 2018-04-20 | Iniziato | Needham | Buy |
| 2018-03-01 | Aggiornamento | Barrington Research | Mkt Perform → Outperform |
| 2017-08-28 | Downgrade | Raymond James | Strong Buy → Outperform |
| 2017-07-20 | Iniziato | BofA/Merrill | Buy |
| 2017-06-20 | Iniziato | SunTrust | Buy |
| 2017-04-05 | Iniziato | Wells Fargo | Outperform |
Mostra tutto
Merit Medical Systems Inc Borsa (MMSI) Ultime notizie
Here's Why You Should Retain DaVita Stock in Your Portfolio for Now - Zacks Investment Research
Reasons to Retain Hims & Hers Stock in Your Portfolio for Now - Zacks Investment Research
10x Genomics & Fred Hutch Join Forces on Cancer Biomarker Research - Zacks Investment Research
Merit Medical Systems, Inc. (MMSI) Stock Forecasts - Yahoo Finance
Reasons to Retain Fresenius Medical Stock in Your Portfolio for Now - Zacks Investment Research
Q3 2025 Merit Medical Systems Inc Earnings Call Transcript - GuruFocus
Merit Medical Systems Inc Annual Shareholders Meeting Transcript - GuruFocus
Merit Medical Systems to Announce Third Quarter 2026 Results on October 29, 2026 - www.marketscreener.com
Merit Medical Systems, Inc. (MMSI) Stock forecasts - Yahoo Finance UK
HSIC or MMSI: Which Is the Better Value Stock Right Now? - Zacks Investment Research
Here's Why You Should Add Merit Medical Stock to Your Portfolio Now - TradingView
Here's Why You Should Add Merit Medical Stock to Your Portfolio Now - TradingView
Reasons to Retain Cardinal Health Stock in Your Portfolio for Now - Zacks Investment Research
Merit Medical Systems (MIL:1MMSI) Cyclically Adjusted PS Ra - GuruFocus
Merit Medical Systems (MIL:1MMSI) Cyclically Adjusted Price-to-FCF : (As of Oct. 06, 2026) - GuruFocus
Merit Medical Systems Inc (MIL:1MMSI) Valuation - GuruFocus
Merit Medical Systems Inc (MIL:1MMSI) Stock HoldersInstitutional & Insider Ownership - GuruFocus
MIL:1MMSI ROE %: 9.40% — 87% Above Median - GuruFocus
Merit Medical Systems Inc (MIL:1MMSI) Stock Price & 30 Year Financial Data - GuruFocus
Merit Medical Systems Inc (MIL:1MMSI) Stock Price, Trades & News - GuruFocus
Merit Medical Systems, Inc. (MMSI) Stock forecasts - Yahoo Finance UK
Zacks Industry Outlook Highlights McKesson, Cardinal Health, Becton, Dickinson, Merit Medical Systems and ProDex - Zacks Investment Research
Zacks Industry Outlook Highlights McKesson, Cardinal Health, Becton, Dickinson, Merit Medical Systems and ProDex - Yahoo Finance
Merit Medical Systems (NasdaqGS:MMSI) Stock Forecast & Analyst Predictions - Simply Wall Street
Merit Medical Systems, Inc. (MMSI) Stock Forecasts - Yahoo! Finance Canada
5 Medical Dental Supply Stocks to Watch as Industry Prospects Improve - Zacks Investment Research
Merit Medical Systems, Inc. (MMSI) Stock Forecasts - Yahoo Finance
MMSI Reiterated by Needham -- Price Target Maintained at $101 - GuruFocus
Merit Medical Systems, Inc. (MMSI) Stock forecasts - Yahoo Finance UK
Merit Medical Systems, Inc. (MMSI) Stock Forecasts - Yahoo Finance
Merit Medical Systems, Inc. (MMSI) Stock Price, News, Quote & History - ca.finance.yahoo.com
(MMSI) Movement as an Input in Quant Signal Sets - Stock Traders Daily
Merit Medical Systems, Inc. (MMSI) stock price, news, quote and history - Yahoo Finance UK
2 Reasons to Sell MMSI and 1 Stock to Buy Instead - Yahoo Finance
Merit Medical Systems, Inc. (MMSI) Stock Analysis: 18.84% Potential Upside Beckons Investors - DirectorsTalk Interviews
2 Reasons to Sell MMSI and 1 Stock to Buy Instead - The Globe and Mail
MMSI PE Ratio & Valuation, Is MMSI Overvalued - Intellectia AI
The Technical Signals Behind (MMSI) That Institutions Follow - Stock Traders Daily
Motorola Solutions stock gains as buyback boost follows strong Q2 figures - ad-hoc-news.de
Merit Medical at Wells Fargo conference: strategic review deepens By Investing.com - Investing.com South Africa
Motorola Solutions stock gains after strong Q2 guidance raise - ad-hoc-news.de
Merit Medical at Wells Fargo conference: strategic review deepens - Investing.com
Merit Medical at Wells Fargo conference: strategic review deepens By Investing.com - Investing.com Canada
Motorola Solutions stock heads into the open after a 0.7% slip - ad-hoc-news.de
Motorola Solutions (MSI) Expands Share Repurchase Program by $2 Billion, Boosting Total Authorization to $20 Billion - GuruFocus
Motorola Solutions Announces Increase to Share Repurchase Program - 01net
Motorola Solutions boosts buyback program by $2 billion - investing.com
Motorola Solutions boosts buyback program by $2 billion - Investing.com Canada
Motorola Solutions CTO to speak at Piper Sandler conference - Investing.com
Motorola Solutions CTO to speak at Piper Sandler conference By Investing.com - Investing.com Canada
Merit Medical Systems Inc Azioni (MMSI) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
Merit Medical Systems Inc Azioni (MMSI) insider trading
| Commercio interno | Relazione | Data | Transazione | Costo | #Azioni | Valore ($) | #Azioni Totale |
|---|---|---|---|---|---|---|---|
| NEIL W PETERSON | Officer |
Aug 24 '26 |
Proposed Sale |
90.45 |
7,500 |
678,360 |
0 |
| NEIL W PETERSON | Officer |
Aug 04 '26 |
Proposed Sale |
85.00 |
21,449 |
1,823,165 |
0 |
| Peterson Neil W. | CHIEF OPERATING OFFICER |
Aug 04 '26 |
Sale |
85.00 |
21,449 |
1,823,165 |
25,551 |
| Gunderson Thomas J. | Director |
May 20 '26 |
Option Exercise |
52.17 |
21,250 |
1,108,612 |
60,741 |
| Smith Christian Adam | Chief Commercial Officer |
May 11 '26 |
Buy |
61.00 |
1,626 |
99,186 |
2,220 |
| Lloyd Brian G. | CHIEF LEGAL OFFICER, SECRETARY |
May 07 '26 |
Buy |
62.62 |
2,000 |
125,250 |
2,000 |
| LYNNE WARD | Director |
May 07 '26 |
Proposed Sale |
62.61 |
5,000 |
313,036 |
0 |
| Ward Lynne N. | Director |
May 07 '26 |
Sale |
62.61 |
5,000 |
313,035 |
7,809 |
| Aronson Martha Goldberg | President and CEO |
May 06 '26 |
Buy |
60.44 |
2,000 |
120,880 |
49,792 |
| Parra Raul Jr. | CFO AND TREASURER |
May 06 '26 |
Buy |
61.01 |
1,500 |
91,515 |
58,843 |
0.99%
0.45%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):